{"id":476678,"date":"2021-04-15T07:04:14","date_gmt":"2021-04-15T11:04:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\/"},"modified":"2021-04-15T07:04:14","modified_gmt":"2021-04-15T11:04:14","slug":"valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\/","title":{"rendered":"Valeo Pharma Announces Commercial Launch of Redesca\u2122 and Redesca HP\u2122"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<ul type=\"disc\">\n<li>\n          <b>Shipments have commenced across <span class=\"xn-location\">Canada<\/span><\/b>\n        <\/li>\n<li>\n          <b>National sales coverage in full deployment through a dedicated key account managers team<\/b>\n        <\/li>\n<li>\n          <b>Private and public reimbursement activities on target.<\/b><br \/>\n          \n        <\/li>\n<\/ul>\n<p>\n        <span class=\"xn-location\">MONTREAL<\/span>, <span class=\"xn-chron\">April 15, 2021<\/span> \/PRNewswire\/ &#8211; <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3130069-1&amp;h=3406954830&amp;u=https%3A%2F%2Fwww.valeopharma.com%2F&amp;a=Valeo+Pharma+Inc\" rel=\"nofollow noopener\">Valeo Pharma Inc<\/a>. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (&#8220;<b>Valeo<\/b>&#8221; or the &#8220;<b>Company<\/b>&#8220;), a Canadian pharmaceutical company, announced today that it has commenced commercial shipments across <span class=\"xn-location\">Canada<\/span> of Redesca\u2122 and Redesca HP\u2122, its low molecular weight heparin (&#8220;LMWH&#8221;) biosimilar. \u00a0<\/p>\n<p>&#8220;Making Redesca\u2122 widely available in <span class=\"xn-location\">Canada<\/span> is a key element \u00a0of our commercialization plans and we are pleased to have done so ahead of target. We continue to work on expanding both public and private reimbursement coverage across all provinces&#8221;, said <span class=\"xn-person\">Steve Saviuk<\/span>, Valeo&#8217;s Chief Executive Officer. &#8221; Redesca\u2122 is the first of three transformative products that Valeo is launching this year and it will be accretive to second quarter revenues with increasing sales growth in the quarters to come.&#8221;<\/p>\n<p>Commenting on the Redesca\u2122 commercial launch, <span class=\"xn-person\">Frederic Fasano<\/span>, Valeo&#8217;s President and Chief Operating Officer said; &#8220;Redesca\u2122 is now available for patients, both at retail pharmacies and hospitals. The combination of a strong and proven safety profile, a complete product line, a robust supply chain on top of material savings to payers, contributes to the compelling Redesca\u2122 value proposition for patients, clinicians and healthcare systems. We look forward to realizing Redesca\u2122&#8217;s full potential over the coming quarters&#8221;. <\/p>\n<p>In addition to being used primarily for treating and preventing deep vein thrombosis and pulmonary embolism, LMWH are also now increasingly used as a first line of defense tool in the fight against COVID-19. The World Health Organization&#8217;s (&#8220;WHO&#8221;) issued guidance regarding the prophylaxis use of LMWH to help prevent complications in the clinical management of severe acute respiratory infections when novel coronavirus (COVID-19) infection is suspected.<\/p>\n<p>\n        <b>About Redesca\u00ae, Redesca HP\u00ae <\/b>\n      <\/p>\n<p>Redesca\u00ae is a low molecular weight heparin biosimilar. LMWHs are injectable anticoagulant drugs used primarily to treat and prevent deep vein thrombosis and pulmonary embolism. Redesca\u00ae has more than 8 years of proven in-market safety internationally and more than 150 million patient days treated in <span class=\"xn-location\">Europe<\/span> alone.<\/p>\n<p>\n        <b>About Valeo Pharma <\/b>\n      <\/p>\n<p>Valeo Pharma is a Canadian pharmaceutical company dedicated to the commercialization of innovative prescription products in <span class=\"xn-location\">Canada<\/span> with a focus on Respiratory Diseases, Neurodegenerative Diseases, Oncology and Hospital Specialty Products. Headquartered in <span class=\"xn-location\">Kirkland, Quebec<\/span> Valeo Pharma has all the required capabilities and the full infrastructure to register and properly manage its growing product portfolio through all stages of commercialization. For more information, please visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3130069-1&amp;h=3166384202&amp;u=http%3A%2F%2Fwww.valeopharma.com%2F&amp;a=www.valeopharma.com\" rel=\"nofollow noopener\">www.valeopharma.com<\/a><b>\u00a0<\/b>and follow us on <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3130069-1&amp;h=2183938588&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fvaleo-pharma&amp;a=LinkedIn\" rel=\"nofollow noopener\">LinkedIn<\/a>\u00a0and <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3130069-1&amp;h=2233143901&amp;u=https%3A%2F%2Ftwitter.com%2Fvaleo_pharma%3Flang%3Den&amp;a=Twitter\" rel=\"nofollow noopener\">Twitter<\/a><b>.<\/b><\/p>\n<p>\n        <b>Forward Looking Statements<\/b>\n      <\/p>\n<p>This press release contains forward-looking statements about Valeo&#8217;s objectives, strategies and businesses that involve risks and uncertainties. These statements are &#8220;forward-looking&#8221; because they are based on our current expectations about the markets we operate in and on various estimates and assumptions. Actual events or results may differ materially from those anticipated in these forward-looking statements if known or unknown risks affect our business, or if our estimates or assumptions turn out to be inaccurate. <\/p>\n<p>NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. <\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=MO43632&amp;sd=2021-04-15\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp-301269561.html\">http:\/\/www.prnewswire.com\/news-releases\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp-301269561.html<\/a><\/p>\n<p>SOURCE  Valeo Pharma Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=MO43632&amp;Transmission_Id=202104150700PR_NEWS_USPR_____MO43632&amp;DateId=20210415\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire Shipments have commenced across Canada National sales coverage in full deployment through a dedicated key account managers team Private and public reimbursement activities on target. MONTREAL, April 15, 2021 \/PRNewswire\/ &#8211; Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (&#8220;Valeo&#8221; or the &#8220;Company&#8220;), a Canadian pharmaceutical company, announced today that it has commenced commercial shipments across Canada of Redesca\u2122 and Redesca HP\u2122, its low molecular weight heparin (&#8220;LMWH&#8221;) biosimilar. \u00a0 &#8220;Making Redesca\u2122 widely available in Canada is a key element \u00a0of our commercialization plans and we are pleased to have done so ahead of target. We continue to work on expanding both public and private reimbursement coverage across all provinces&#8221;, said Steve Saviuk, Valeo&#8217;s Chief Executive Officer. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Valeo Pharma Announces Commercial Launch of Redesca\u2122 and Redesca HP\u2122&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-476678","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Valeo Pharma Announces Commercial Launch of Redesca\u2122 and Redesca HP\u2122 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Valeo Pharma Announces Commercial Launch of Redesca\u2122 and Redesca HP\u2122 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Shipments have commenced across Canada National sales coverage in full deployment through a dedicated key account managers team Private and public reimbursement activities on target. MONTREAL, April 15, 2021 \/PRNewswire\/ &#8211; Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (&#8220;Valeo&#8221; or the &#8220;Company&#8220;), a Canadian pharmaceutical company, announced today that it has commenced commercial shipments across Canada of Redesca\u2122 and Redesca HP\u2122, its low molecular weight heparin (&#8220;LMWH&#8221;) biosimilar. \u00a0 &#8220;Making Redesca\u2122 widely available in Canada is a key element \u00a0of our commercialization plans and we are pleased to have done so ahead of target. We continue to work on expanding both public and private reimbursement coverage across all provinces&#8221;, said Steve Saviuk, Valeo&#8217;s Chief Executive Officer. &hellip; Continue reading &quot;Valeo Pharma Announces Commercial Launch of Redesca\u2122 and Redesca HP\u2122&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-15T11:04:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=MO43632&amp;sd=2021-04-15\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Valeo Pharma Announces Commercial Launch of Redesca\u2122 and Redesca HP\u2122\",\"datePublished\":\"2021-04-15T11:04:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\\\/\"},\"wordCount\":546,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=MO43632&amp;sd=2021-04-15\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\\\/\",\"name\":\"Valeo Pharma Announces Commercial Launch of Redesca\u2122 and Redesca HP\u2122 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=MO43632&amp;sd=2021-04-15\",\"datePublished\":\"2021-04-15T11:04:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=MO43632&amp;sd=2021-04-15\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=MO43632&amp;sd=2021-04-15\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Valeo Pharma Announces Commercial Launch of Redesca\u2122 and Redesca HP\u2122\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Valeo Pharma Announces Commercial Launch of Redesca\u2122 and Redesca HP\u2122 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\/","og_locale":"en_US","og_type":"article","og_title":"Valeo Pharma Announces Commercial Launch of Redesca\u2122 and Redesca HP\u2122 - Market Newsdesk","og_description":"PR Newswire Shipments have commenced across Canada National sales coverage in full deployment through a dedicated key account managers team Private and public reimbursement activities on target. MONTREAL, April 15, 2021 \/PRNewswire\/ &#8211; Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (&#8220;Valeo&#8221; or the &#8220;Company&#8220;), a Canadian pharmaceutical company, announced today that it has commenced commercial shipments across Canada of Redesca\u2122 and Redesca HP\u2122, its low molecular weight heparin (&#8220;LMWH&#8221;) biosimilar. \u00a0 &#8220;Making Redesca\u2122 widely available in Canada is a key element \u00a0of our commercialization plans and we are pleased to have done so ahead of target. We continue to work on expanding both public and private reimbursement coverage across all provinces&#8221;, said Steve Saviuk, Valeo&#8217;s Chief Executive Officer. &hellip; Continue reading \"Valeo Pharma Announces Commercial Launch of Redesca\u2122 and Redesca HP\u2122\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-15T11:04:14+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=MO43632&amp;sd=2021-04-15","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Valeo Pharma Announces Commercial Launch of Redesca\u2122 and Redesca HP\u2122","datePublished":"2021-04-15T11:04:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\/"},"wordCount":546,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=MO43632&amp;sd=2021-04-15","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\/","name":"Valeo Pharma Announces Commercial Launch of Redesca\u2122 and Redesca HP\u2122 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=MO43632&amp;sd=2021-04-15","datePublished":"2021-04-15T11:04:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=MO43632&amp;sd=2021-04-15","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=MO43632&amp;sd=2021-04-15"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/valeo-pharma-announces-commercial-launch-of-redesca-and-redesca-hp\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Valeo Pharma Announces Commercial Launch of Redesca\u2122 and Redesca HP\u2122"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/476678","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=476678"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/476678\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=476678"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=476678"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=476678"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}